Jane Street Group, LLC Cure Vac N.V. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Jane Street Group, LLC holds 79,247 shares of CVAC stock, worth $227,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,247

Previous 23,380 238.95%

Holding current value

$227,438

Previous $79,000 193.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.74 - $3.79 $153,075 - $211,735	55,867 Added 238.95%	79,247 $232,000
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $54,007 - $116,666	23,380 New	23,380 $79,000
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $199,690 - $323,237	50,427 Added 201.62%	75,438 $317,000
Q3 2023 Nov 14, 2023	SELL	$6.5 - $10.77 $136,344 - $225,911	-20,976 Reduced 45.61%	25,011 $170,000
Q2 2023 Aug 14, 2023	BUY	$6.69 - $12.25 $307,653 - $563,340	45,987 New	45,987 $479,000
Q2 2022 Aug 16, 2022	BUY	$13.18 - $19.41 $1.34 Million - $1.97 Million	101,578 Added 176.14%	159,247 $2.14 Million
Q1 2022 May 17, 2022	BUY	$14.73 - $35.25 $726,851 - $1.74 Million	49,345 Added 592.8%	57,669 $1.12 Million
Q4 2021 Feb 15, 2022	SELL	$33.72 - $48.22 $2.32 Million - $3.32 Million	-68,945 Reduced 89.23%	8,324 $287,000
Q3 2021 Nov 16, 2021	BUY	$49.26 - $74.5 $727,471 - $1.1 Million	14,768 Added 23.63%	77,269 $4.23 Million
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $3.1 Million - $6.94 Million	54,406 Added 672.09%	62,501 $4.59 Million
Q1 2021 May 18, 2021	SELL	$79.79 - $126.29 $4.37 Million - $6.91 Million	-54,749 Reduced 87.12%	8,095 $741,000
Q4 2020 Feb 17, 2021	BUY	$46.76 - $136.27 $1.23 Million - $3.59 Million	26,323 Added 72.08%	62,844 $5.1 Million
Q3 2020 Nov 17, 2020	BUY	$43.8 - $77.2 $1.6 Million - $2.82 Million	36,521 New	36,521 $1.7 Million

Others Institutions Holding CVAC

# of Institutions

Shares Held

12.3M

Call Options Held

164K

Put Options Held

117K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Cure Vac N.V. Transaction History